Results 61 to 70 of about 1,027,648 (153)
National Drugs Advisory Board annual report and accounts, 1994
The National Drugs Advisory Board was established by the Minister for Health in 1966 by the National Drugs Advisory Board (Establishment) Order 1966 (5.1. No. 163 of 1966) under the Health (Corporate Bodies) Act 1961.
National Drugs Advisory Board (NDAB)
core
Factors affecting patients’ self-management in chronic venous disorders: a single-center study
Kamil Barański,1,2 Jerzy Chudek2,3 1Department of Epidemiology, Medical School in Katowice, 2Department of Pathophysiology, Medical University of Silesia, Katowice, 3Angiology Outpatient Clinic “Combi-Med,” Częstochowa, Poland Background ...
Barański K, Chudek J
doaj
Vascular Pain: A Narrative Review on Venous Leg Ulcers
Background: Venous leg ulcers (VLUs) affect 1-3% of the population and impose substantial pain-related morbidity, yet vascular pain remains underrecognized in clinical practice and research.
Giustino Varrassi +6 more
doaj +1 more source
Reports of side effects associated with the use of drugs 1976
The National Drugs Advisory Board received 463 reports in all during 1976. From these 844 adverse reactions were recorded associated with the use of drugs during the year. There were 13 cases of drug interactions - these are listed separately.
National Drugs Advisory Board (NDAB)
core
National Drugs Advisory Board annual report 1975
By the end of 1975. the National Drugs Advisory Board had 15 months of experience in the management of mandatory licensing systems for medicinal products and for manufacturers of pharmaceuticals in Ireland. With few exceptions.
National Drugs Advisory Board (NDAB)
core
Reports of side effects associated with the use of drugs 1986
During 1986 the National Drugs Advisory Board received 1,188 reports of adverse reactions from which 2,454 side effects were recorded. These results represent an increase of approximately 20% in reporting.
National Drugs Advisory Board (NDAB)
core
Local and regional drugs task forces: handbook.
This handbook has been developed within the context of the institutional structures recommended under the National Drugs Strategy 2009-2016 and within the overall framework of the National Social Inclusion Plan 2007-2016.
Drugs Advisory Group
core +1 more source
Characteristics of product recalls of biopharmaceuticals and small-molecule drugs in the USA [PDF]
Compared with chemically synthesized small-molecule drugs, the manufacturing process of biopharmaceuticals is more complex. Unexpected changes to product characteristics following manufacturing changes have given rise to calls for robust systems to ...
Mantel-Teeuwisse, Aukje K +7 more
core +2 more sources
Report of side effects associated with the use of drugs 1981
The National Drugs Advisory Board received 662 reports during 1981 from which 1264 side-effects were recorded. Of these 33.3% concerned drugs affecting the central nervous system and 27% involved anti-infective drugs. Of the drugs affecting the central
National Drugs Advisory Board (NDAB)
core
Venoactive drug therapy in surgical or endovenous treatment for varicose veins [PDF]
openaire +1 more source

